Trial Profile
Rituximab plus a CHOP-like regimen, central nervous system prophylaxis, and contralateral testicular irradiation for localized primary testicular diffuse large B-cell lymphoma lead to prolonged progression-free survival.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Antineoplastics
- Indications Diffuse large B cell lymphoma; Testicular cancer
- Focus Therapeutic Use
- 22 Dec 2015 New trial record